Skip to main content

Table 2 Aggregated results of Working Group 3 (A, B, and C)

From: Evaluation of dialysis centres: values and criteria of the stakeholders

 PatientsCliniciansManagersTotal
(n = 9)(n = 9)(n = 8)(n = 26)
CriteriaSub-criteriaMethodology    
EBV WS26.11 (10.83)26.66 (7.50)24.37 (10.16)25.77 (9.24)
  AHP20.31 (15.06)24.62 (17.60)29.50 (22.25)24.63 (18.02)
 Type of vascular accessWS25.55 (8.46)26.67 (4.33)28.75 (5.18)26.92 (6.17)
 AHP41.66 (11.38)40.42 (11.41)31.98 (14.37)38.25 (12.63)
 Dialysis doseWS26.11 (8.21)20.56 (3.01)21.87 (5.94)22.88 (6.35)
 AHP18.63 (10.45)21.17 (11.19)19.75 (11.95)19.85 (10.78)
 Haemoglobin concentrationWS16.11 (4.17)18.33 (2.50)15.62 (4.17)16.73 (3.73)
 AHP13.36 (6.18)11.03 (7.57)10.61 (7.00)11.71 (6.78)
 Ratio of bacteraemia related to the catheterWS16.11 (8.21)21.67 (7.50)25.00 (3.78)20.77 (7.57)
 AHP19.93 (11.95)23.61 (10.91)19.29 (20.68)21.01 (14.40)
 Mineral and bone diseaseWS16.11 (6.97)12.78 (7.12)8.75 (3.54)12.69 (6.67)
 AHP6.42 (3.47)3.77 (0.99)18.36 (14.22)9.18 (10.05)
Morbidity, annualWS15.56 (7.68)18.89 (5.46)18.37 (8.43)17.57 (7.12)
AHP23.06 (7.98)13.15 (9.35)15.72 (9.88)17.38 (9.72)
Mortality, annualWS12.22 (7.55)18.89 (6.50)20.00 (9.26)16.92 (8.26)
AHP13.76 (13.75)20.51 (20.71)20.68 (20.02)18.23 (17.91)
PROMsWS28.33 (5.00)21.67 (4.33)26.25 (7.44)25.38 (6.15)
AHP36.26 (16.76)31.93 (12.45)23.33 (13.23)30.78 (14.75)
PREMsWS17.78 (6.18)13.89 (3.33)11.00 (2.56)14.34 (5.05)
AHP6.61 (3.35)9.77 (5.78)10.75 (11.94)8.98 (7.58)
  1. The disaggregated results are shown by category of stakeholder (patient, clinician, and manager) and by methodology (WS and AHP). The first weight is not given to simplify the table. Data are given as mean (SD)
  2. EBV evidence-based variables, WS weighted sum, AHP analytic hierarchy process, PROM patient reported outcome measure, PREM patient reported experience measure, SD standard deviation